Finke JH - Search Results

1

Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas.

Thornton MV, Kudo D, Rayman P, Horton C, Molto L, Cathcart MK, Ng C, Paszkiewicz-Kozik E, Bukowski R, Derweesh I, Tannenbaum CS, Finke JH. Thornton MV, et al. Among authors: finke jh. J Immunol. 2004 Mar 15;172(6):3480-90. doi: 10.4049/jimmunol.172.6.3480. J Immunol. 2004. PMID: 15004148

2

The Bcl-2 transgene protects T cells from renal cell carcinoma-mediated apoptosis.

Molto L, Rayman P, Paszkiewicz-Kozik E, Thornton M, Reese L, Thomas JC, Das T, Kudo D, Bukowski R, Finke J, Tannenbaum C. Molto L, et al. Clin Cancer Res. 2003 Sep 15;9(11):4060-8. Clin Cancer Res. 2003. PMID: 14519627

3

Effect of renal cell carcinomas on the development of type 1 T-cell responses.

Rayman P, Wesa AK, Richmond AL, Das T, Biswas K, Raval G, Storkus WJ, Tannenbaum C, Novick A, Bukowski R, Finke J. Rayman P, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6360S-6S. doi: 10.1158/1078-0432.CCR-050011. Clin Cancer Res. 2004. PMID: 15448031

4

TNF-alpha induction of GM2 expression on renal cell carcinomas promotes T cell dysfunction.

Raval G, Biswas S, Rayman P, Biswas K, Sa G, Ghosh S, Thornton M, Hilston C, Das T, Bukowski R, Finke J, Tannenbaum CS. Raval G, et al. J Immunol. 2007 May 15;178(10):6642-52. doi: 10.4049/jimmunol.178.10.6642. J Immunol. 2007. PMID: 17475896

5

Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells.

Kudo D, Rayman P, Horton C, Cathcart MK, Bukowski RM, Thornton M, Tannenbaum C, Finke JH. Kudo D, et al. Among authors: finke jh. Cancer Res. 2003 Apr 1;63(7):1676-83. Cancer Res. 2003. PMID: 12670922

6

Mechanisms of immune dysfunction in renal cell carcinoma.

Derweesh IH, Tannenbaum CS, Rayman PA, Finke JH. Derweesh IH, et al. Among authors: finke jh. Cancer Treat Res. 2003;116:29-51. doi: 10.1007/978-1-4615-0451-1_2. Cancer Treat Res. 2003. PMID: 14650824 Review. No abstract available.

7

GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction.

Biswas K, Richmond A, Rayman P, Biswas S, Thornton M, Sa G, Das T, Zhang R, Chahlavi A, Tannenbaum CS, Novick A, Bukowski R, Finke JH. Biswas K, et al. Among authors: finke jh. Cancer Res. 2006 Jul 1;66(13):6816-25. doi: 10.1158/0008-5472.CAN-06-0250. Cancer Res. 2006. PMID: 16818659

8

CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors.

Gorbachev AV, Kobayashi H, Kudo D, Tannenbaum CS, Finke JH, Shu S, Farber JM, Fairchild RL. Gorbachev AV, et al. Among authors: finke jh. J Immunol. 2007 Feb 15;178(4):2278-86. doi: 10.4049/jimmunol.178.4.2278. J Immunol. 2007. PMID: 17277133

9

Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways.

Das T, Sa G, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman P, Kudo D, Biswas K, Bukowski RM, Finke JH, Tannenbaum CS. Das T, et al. Among authors: finke jh. J Immunol. 2008 Apr 1;180(7):4687-96. doi: 10.4049/jimmunol.180.7.4687. J Immunol. 2008. PMID: 18354192

10

Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction.

Biswas S, Biswas K, Richmond A, Ko J, Ghosh S, Simmons M, Rayman P, Rini B, Gill I, Tannenbaum CS, Finke JH. Biswas S, et al. Among authors: finke jh. J Immunol. 2009 Oct 15;183(8):5050-8. doi: 10.4049/jimmunol.0900259. J Immunol. 2009. PMID: 19801523 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters